跳至主要内容
临床试验/CTRI/2023/06/054302
CTRI/2023/06/054302已完成Unknown

A Prospective, Single arm, Open label, Single centre Clinical study to evaluate the Safety and Efficacy of Nimson Coconut Jasmin oil with Vitamin E in improving Hair Growth.

Aryanveda Cosmeceuticals1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年6月30日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
To test the Efficacy of the coconut jasmine oil with vitamin E in increasing the hair growth and repairing damaged hair.

研究概览

简要总结

A prospective ,single arm, open label, single centre clinical study to evaluate the safety and efficacy of Nimson coconut jasmin oil with vitamin E in improving hair growth.

Primary Objective :

To evaluate the capacity of Nimson coconut jasmine oil to nourish the hair evaluated by change in investigator assessment score for hair count and percentage of subjects responding to therapy.

Secondary Objective

• To test the efficacy of the coconut jasmine oil with Vitamin E .in the nourishment of the scalp .

• Frequency of the adverse events

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • •Subjects aged between 18 to 65 years.
  • • Patients having Khalitya (Hair fall) as per Ayurvedic classical texts and as per modern parameters i.e., Hair fall, Dandruff and Dryness of hairs have been selected irrespective of any bar of caste, gender, religion and occupation.

排除标准

  • Signs of allergy, irritation or intolerance to the components of the test product 2)Patients who have been diagnosed to have local disease like Alopecia areata, Alopecia totalis, Tinea capitis, Folliculitis devaculans.
  • Patient with hair fall related to any Systemic disorders, any Hormonal disorders, Post CA treatments and Vitiligo.
  • Pregnancy or lactation.
  • Participation in other clinical trials.
  • Unwilling/unable to sign the informed consent.

结局指标

主要结局

To test the Efficacy of the coconut jasmine oil with vitamin E in increasing the hair growth and repairing damaged hair.

时间窗: 6 weeks

次要结局

  • • Adverse events & its percentage(• Treatment discontinuation rates: Early discontinuation, discontinuation due to adverse events)

研究者

发起方
Aryanveda Cosmeceuticals
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验